| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 2,070,632 | 10,422 | | Cost of Revenue | 1,811,454 |
-
| | | Gross Profit | 259,178 | 10,422 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 82,536 | 333 | | Non Recurring | 29,780 | 1 | | Others | 109,988 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 36,874 | 10,088 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 |
-
| | Earnings Before Interest And Taxes | 36,925 | 10,088 | | Interest Expense | 91,220 | 6 | | Income Before Tax | (54,295) | 10,082 | | Income Tax Expense | (8,772) | 4,590 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (45,523) | 5,492 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (45,523) | 5,492 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($45,523) | $5,492 |
|
1.00% Nasdaq 0.00%
Income Statement
